We showed that, during acute COVID-19, plasma NfL levels were (i) significantly increased; (ii) correlated with markers of COVID-19 severity, such as CRP, degree of respiratory insufficiency, lymphocyte and neutrophil absolute counts, and neutrophil to lymphocyte ratio; and (iii) predicted clinical outcomes [13]. The gene discussed is CRP; the disease is COVID-19.